AgeX Therapeutics, Inc. (AGE)

EBITDA

-$6.78M

Quarterly · Period ending: · USD

AGE logo

AGE EBITDA

Latest reported-$6.78M
AGE Quarterly EBITDA (-$3.43M → -$6.78M)
High-resolution chart · PNG

AGE ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-6,784,000
18,000
-6,207,000
-4,563,000
-6,423,000
17,000
15,506,000
80,000
-3,866,000
-9,511,000
-3,481,000
-2,320,000
-1,854,000
-2,152,000
-1,750,000
-1,480,000
-1,722,000
-2,103,000
-1,831,000
-1,638,000
-2,168,000
-4,147,000
-2,030,553
-2,344,000
-2,450,000
-2,803,000
-2,422,000
-3,279,000
-3,191,000
-2,973,000
-3,358,000
-2,056,000
-2,017,000
-3,429,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.